( MENAFN - GlobeNewsWire - Nasdaq) Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Dentsply To Contact Him Directly ...

Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Dentsply To Contact Him Directly To Discuss Their Options ...

Inspira Technologies OXY B.H.N. Ltd. ("Inspira" or the "Company"), a leader in life-support technology innovation, announced today that it is preparing for a potential production ramp-up of its ...

Levi & Korsinsky, LLP notifies investors in Dentsply Sirona Inc. ("Dentsply" or the "Company") of a class action securities ...

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

DENTSPLY SIRONA Inc (XRAY) stock saw a modest uptick, ending the day at $18.85 which represents a slight increase of $0.24 or 1.29% from the prior close of $18.61. The stock opened at $18.51 and ...

NDAQ:XRAY) ROSEN, A LEADING LAW FIRM, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRAY ...

Rising incidence of oral cancer along with an increase in the number of dental treatments is expected to propel the global ...

During his successful tenure at PepsiCo Canada, he held three Vice President roles and delivered exceptional results by ...

DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 43rd Annual J.P. Morgan Healthcare Conference. Management is scheduled ...

In a report released today, Allen Lutz from Bank of America Securities maintained a Hold rating on DENTSPLY SIRONA (XRAY – Research Report).

Fintel reports that on January 7, 2025, Evercore ISI Group downgraded their outlook for DENTSPLY SIRONA (NasdaqGS:XRAY) from ...